AU2016210540B2 - Chlorophyll composition - Google Patents

Chlorophyll composition Download PDF

Info

Publication number
AU2016210540B2
AU2016210540B2 AU2016210540A AU2016210540A AU2016210540B2 AU 2016210540 B2 AU2016210540 B2 AU 2016210540B2 AU 2016210540 A AU2016210540 A AU 2016210540A AU 2016210540 A AU2016210540 A AU 2016210540A AU 2016210540 B2 AU2016210540 B2 AU 2016210540B2
Authority
AU
Australia
Prior art keywords
chlorophyllin
composition
serum creatinine
ingredient
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2016210540A
Other languages
English (en)
Other versions
AU2016210540A1 (en
Inventor
Chitra Vasant Savangikar
Vasant Anantrao Savangikar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2016210540A1 publication Critical patent/AU2016210540A1/en
Application granted granted Critical
Publication of AU2016210540B2 publication Critical patent/AU2016210540B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2016210540A 2015-01-19 2016-01-15 Chlorophyll composition Active AU2016210540B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN178MU2015 2015-01-19
IN178/MUM/2015 2015-01-19
PCT/IN2016/050017 WO2016116950A2 (en) 2015-01-19 2016-01-15 Chlorophyll composition

Publications (2)

Publication Number Publication Date
AU2016210540A1 AU2016210540A1 (en) 2017-08-10
AU2016210540B2 true AU2016210540B2 (en) 2018-10-11

Family

ID=56417899

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016210540A Active AU2016210540B2 (en) 2015-01-19 2016-01-15 Chlorophyll composition

Country Status (10)

Country Link
US (2) US12194052B2 (enExample)
EP (1) EP3247323B1 (enExample)
JP (3) JP6772151B2 (enExample)
CN (2) CN107427417A (enExample)
AU (1) AU2016210540B2 (enExample)
BR (1) BR112017015338A2 (enExample)
EA (1) EA201791319A1 (enExample)
ES (1) ES2879996T3 (enExample)
SG (1) SG11201705694VA (enExample)
WO (1) WO2016116950A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2879996T3 (es) * 2015-01-19 2021-11-23 Chitra Vasant Savangikar Composición de clorofila
EP4059493A1 (en) * 2021-03-16 2022-09-21 The Secretary, Department Of Atomic Energy A chlorophyllin containing pharmaceutical composition for prevention of pathogenesis of coronavirus disease
WO2025203055A1 (en) * 2024-03-26 2025-10-02 Council Of Scientific And Industrial Research Encapsulated dihydrofolate formulation for dietary supplementation as effective nutraceutical supplement and method of preparation thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55161863A (en) * 1979-06-06 1980-12-16 Paaku Deebisu Kk Colored gelatin capsule
DE4033530A1 (de) * 1990-10-22 1992-04-23 Univ Schiller Jena Kristallisationsinhibitor
JPH04327534A (ja) * 1991-04-24 1992-11-17 Mitsuo Namiki 活性酸素による障害の予防及び治療剤
CN102138919A (zh) * 2011-01-28 2011-08-03 武汉联合药业有限责任公司 铁叶绿酸钠用于促进红细胞生成的新用途
CN103027873A (zh) * 2011-10-10 2013-04-10 马美琳 一种消炎止血牙膏

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2729586A (en) 1952-02-01 1956-01-03 Rystan Company Therapeutic compositions comprising water - soluble chlorophyll and salts of fatty acids
BE516996A (enExample) 1952-02-19
JPH04356420A (ja) * 1991-05-31 1992-12-10 Nisshin Flour Milling Co Ltd チアミン・コバルト・クロロフィリン錯化合物含有組成物
JP3734360B2 (ja) * 1998-03-18 2006-01-11 エーザイ株式会社 銅クロロフィリンの塩を含有してなる製剤
CN1078468C (zh) 1998-07-02 2002-01-30 许德余 叶绿素铜钠盐用于制造抗胃粘膜损伤的组合物的用途
JP3657203B2 (ja) 2000-04-21 2005-06-08 エーザイ株式会社 銅クロロフィリン塩含有液剤組成物
JP2003081741A (ja) * 2001-09-13 2003-03-19 Nikko Seiyaku Kk 皮膚外用剤
JP4068442B2 (ja) * 2001-12-03 2008-03-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 味覚改善組成物
EP1846106B1 (en) * 2005-01-31 2012-10-24 Dong Wha Pharm. Co., Ltd. Pharmaceutical composition for treating nephropathy and healthy food comprising herb extracts
WO2007143002A2 (en) * 2006-05-31 2007-12-13 Interhealth Nutraceuticals, Inc. Nutraceutical treatments for diabetic and non-diabetic wound healing
US7947827B2 (en) * 2006-06-30 2011-05-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Pharmaceutical formulation comprising a metaloporphyrin and method for its purification and use
CA2691691C (en) 2007-06-20 2013-09-24 Seth J. Baum Compositions and methods of treating chronic kidney disease
JP2009256228A (ja) * 2008-04-15 2009-11-05 Lion Corp 液体口腔用組成物
CN102462671A (zh) 2010-11-18 2012-05-23 何国增 叶绿素铜钠胶囊的制备方法
CN103285097B (zh) 2012-02-22 2014-12-10 西安世纪盛康药业有限公司 肾康注射液在制备防治放疗或化疗所致肾毒性药物中的应用
AU2014205553A1 (en) * 2013-01-08 2015-07-09 Volant Holdings Gmbh Activation of the endogenous ileal brake hormone pathway for organ regeneration and related compositions, methods of treatment, diagnostics, and regulatory systems
ES2879996T3 (es) * 2015-01-19 2021-11-23 Chitra Vasant Savangikar Composición de clorofila

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55161863A (en) * 1979-06-06 1980-12-16 Paaku Deebisu Kk Colored gelatin capsule
DE4033530A1 (de) * 1990-10-22 1992-04-23 Univ Schiller Jena Kristallisationsinhibitor
JPH04327534A (ja) * 1991-04-24 1992-11-17 Mitsuo Namiki 活性酸素による障害の予防及び治療剤
CN102138919A (zh) * 2011-01-28 2011-08-03 武汉联合药业有限责任公司 铁叶绿酸钠用于促进红细胞生成的新用途
CN103027873A (zh) * 2011-10-10 2013-04-10 马美琳 一种消炎止血牙膏

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HOELSCHER, M. et al. "Pharmacological prolongation of ischemic tolerance of rat-kidneys by Na-Cu-chlorophyllin" Transactions - American Society for Artificial Internal Organs (1975) Vol.21 pages 96 to 101 *

Also Published As

Publication number Publication date
AU2016210540A1 (en) 2017-08-10
EP3247323A2 (en) 2017-11-29
EP3247323B1 (en) 2021-03-03
US12194052B2 (en) 2025-01-14
WO2016116950A3 (en) 2016-10-13
CN107427417A (zh) 2017-12-01
WO2016116950A2 (en) 2016-07-28
US20250090546A1 (en) 2025-03-20
ES2879996T3 (es) 2021-11-23
JP2021006555A (ja) 2021-01-21
US20180325915A1 (en) 2018-11-15
EA201791319A1 (ru) 2018-01-31
WO2016116950A4 (en) 2016-12-01
JP6772151B2 (ja) 2020-10-21
JP2018502893A (ja) 2018-02-01
JP2025066799A (ja) 2025-04-23
BR112017015338A2 (pt) 2018-01-09
SG11201705694VA (en) 2017-08-30
CN117100756A (zh) 2023-11-24
EP3247323A4 (en) 2018-07-11

Similar Documents

Publication Publication Date Title
US7887847B2 (en) Nutritional supplement for treatment of ocular diseases
US20250090546A1 (en) Chlorophyll composition
JP5214628B2 (ja) メタドキシンとニンニク油を含有するアルコール性脂肪肝並びに脂肪肝性肝炎の予防及び治療用薬学組成物
US20120052138A1 (en) Composition comprising green tea extract
CN102665725B (zh) 高血脂症改善剂、贫血改善组合物、尿酸值降低组合物以及饮料食品
US20030064937A1 (en) Composition for reducing appetite in mammals
JP2010088403A (ja) アディポネクチン分泌促進用飲食品
JP2012056919A (ja) ヒアルロン酸産生促進剤
JP4119629B2 (ja) 高血圧症予防・改善・治療剤
CN107105695A (zh) 具有增强的抗氧化性的海洋卵磷脂制剂
Fürst The role of antioxidants in nutritional support
KR100304312B1 (ko) 아연이보충된전립선추출물
JP2010159283A (ja) プロアントシアニジン含有組成物
JP2003169633A (ja) 血圧降下、心臓強化、動脈硬化防止、血管保護、抗疲労、運動機能向上、エネルギー代謝効率向上、抗酸化などの諸効果を有する栄養補助食品。
JP2005060338A (ja) プロアントシアニジン含有組成物
WO2018142328A1 (en) Composition for hyperuricemia treatment
EP3235510A1 (en) Nutritional compositions for the management of glucose metabolism
JP4610730B2 (ja) カルシウム補給用の組成物
KR20230056234A (ko) 곤드레 추출물을 유효성분으로 함유하는 환경호르몬에 의한 대사 이상 개선 및 치료용 조성물
JP2010043036A (ja) 糖代謝促進剤
EA048916B1 (ru) Применение хлорофиллина для лечения заболеваний почек, терапевтические композиции хлорофиллина и способ лечения
RU2330679C1 (ru) Композиция для профилактики и лечения астмы и заболеваний верхних дыхательных путей и способ ее получения
RU2847880C1 (ru) Концентрат напитка "Желудочный"
RU2837268C1 (ru) Композиция для энтерального питания
JP6112767B2 (ja) 血液中の尿酸値を低下させるための組成物

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)